243467
Non-Medical Use of Prescription Drugs Among High-risk LGBT Youth
Karol Silva, MPH
,
Community Health and Prevention, Drexel University, School of Public Health, Philadelphia, PA
Jennifer Jackson Bloom, MPH
,
Community, Health Outcomes, and Intervention Research Program, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA
Sheree M. Schrager, PhD
,
Community, Health Outcomes, and Intervention Research Program, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA
Ellen Iverson, MPH
,
Community, Health Outcomes, and Intervention Research Program, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA
Stephen E. Lankenau, PhD
,
Community Health and Prevention, Drexel University, School of Public Health, Philadelphia, PA
Background: Non-medical use of prescription drugs (NMUPD) has been a growing public health problem in the U.S. for the past decade. During this time, limited research has examined NMUPD among high-risk lesbian, gay, bisexual and trans-gender (LGBT) youth. Methods: Data is based upon cross-sectional surveys of 560 high-risk youth (polydrug users, homeless youth, and injection drug users) aged 18 to 25 reporting current NMUPD, recruited in Los Angeles and New York City from 2008 to 2010. History and current patterns of NMUPD and illicit drug use, and rates of sexually transmitted infections (STI) were assessed for LGBT and heterosexual youth. Findings: Numerous statistically significant differences were observed (p=0.05). LGBT youth were more likely to report problematic history of NMUPD than their heterosexual counterparts. LGBT youth initiated NMUPD one year earlier on average, were prescribed more often, reported higher rates of recent use (last 30 days), were more likely to have injected prescription drugs, and were more likely to report family member's history of NMUPD. Interestingly, illicit drug use did not differ between LGBT and heterosexual youth. Additionally, LGBT youth was more likely than heterosexual youth to be diagnosed with HIV, gonorrhea, syphilis, chlamydia, HSV, HPV, but not with Hepatitis C or scabies. Conclusions: Findings suggest that NMUPD among high-risk LGBT youth may be an under-reported feature of the larger prescription drug epidemic in the U.S. These findings should be considered when developing or implementing prevention interventions for LGBT youth. The potential relationship between NMUPD and STI necessitates additional research.
Learning Areas:
Assessment of individual and community needs for health education
Epidemiology
Social and behavioral sciences
Learning Objectives: 1) Describe patterns of prescription drug misuse among high-risk LGBT youth;
2) Identify Non-Medical Use of Prescription Drugs (NMUPD) differences related to sexual orientation;
3) Discuss implications for developing future prevention programs targeting high-risk LGBT youth.
Keywords: Prescription Drug Use Patterns, Youth
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am qualified to be an abstract Author on the content I am responsible for because I have MPH degree, am currently DrPH student, and have conducted research I am submitting for APHA annual meeting.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|